Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.44 |
| ▸ | USP2 | O75604 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | PKM | P14618 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | RGS12 | O14924 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29280376 | 0.87 | SLC7A5 (0.46) | SLC7A5USP2HSD17B10PKMALOX15 | |
| SCHEMBL4994581 | 0.87 | SLC7A5 (0.46) | SLC7A5USP2HSD17B10PKMALOX15 | |
| SCHEMBL4308097 | 0.85 | SLC7A5 (0.41) | SLC7A5USP2HSD17B10PKMALOX15 | |
| SCHEMBL4308098 | 0.85 | SLC7A5 (0.41) | SLC7A5USP2HSD17B10PKMALOX15 | |
| SCHEMBL1076502 | 0.76 | SLC7A5 (0.44) | SLC7A5USP2HSD17B10PKMALOX15 | |
| SCHEMBL24269408 | 0.75 | USP2 (0.43) | SLC7A5USP2HSD17B10PKMALOX15 | |
| SCHEMBL22372474 | 0.73 | SLC7A5 (0.40) | SLC7A5USP2HSD17B10PKMALOX15 | |
| Benzoquinone SCHEMBL4317267 | 0.72 | KDM4E (0.62) | SLC7A5USP2HSD17B10PKMALOX15 | |
| SCHEMBL9315085 | 0.68 | SLC7A5 (0.43) | SLC7A5USP2HSD17B10PKMALOX15 | |
| SCHEMBL9315113 | 0.68 | SLC7A5 (0.43) | SLC7A5USP2HSD17B10PKMALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025090291-A1 | GLASS CONTAINERS AND PHARMACEUTICAL COMPOSITIONS WITH REDUCED BORON INTERACTION | CORNING INCORPORATED (US) | 2025-05-01 | — | — | WO | disclosed |
| US-12018265-B2 | Nucleic acid encoding n-methylputrescine oxidase and uses thereof | 22ND CENTURY LIMITED, LLC (US) | 2024-06-25 | — | — | US | disclosed |
| US-20230029030-A1 | NUCLEIC ACID ENCODING N-METHYLPUTRESCINE OXIDASE AND USES THEREOF | 22ND CENTURY LIMITED, LLC (US) | 2023-01-26 | — | — | US | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-11396656-B2 | Nucleic acid encoding n-methylputrescine oxidase and uses thereof | 22ND CENTURY LIMITED, LLC (US) | 2022-07-26 | — | — | US | disclosed |
| CN-113832119-A | Improved polypeptide capable of converting substrate 3-ketodeoxynivalenol into 3-epi-deoxynivalenol | 艾尔柏股份公司 | 2021-12-24 | — | — | CN | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20200277616-A1 | NUCLEIC ACID ENCODING N-METHYLPUTRESCINE OXIDASE AND USES THEREOF | 22ND CENTURY LIMITED, LLC (US) | 2020-09-03 | — | — | US | disclosed |
| US-10689658-B2 | Nucleic acid encoding N-methylputrescine oxidase and uses thereof | 22ND CENTURY LIMITED, LLC (US) | 2020-06-23 | — | — | US | disclosed |
| CN-107074853-B | The pyridine derived SSAO inhibitor of imidazo [4,5-c] | 普罗克斯马根有限责任公司 | 2019-07-23 | — | — | CN | disclosed |
| US-20110250511-A1 | BIOFUEL CELL | SONY CORPORATION (JP) | 2011-10-13 | — | — | US | disclosed |
| US-20110117453-A1 | FUEL REFORMER AND POWER GENERATION APPARATUS USING THE SAME | SONY CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| US-20090210958-A1 | NUCLEIC ACID ENCODING N-METHYLPUTRESCINE OXIDASE AND USES THEREOF | NATIONAL RESEARCH COUNCIL OF CANADA | 2009-08-20 | — | — | US | disclosed |
| EP-2038406-A2 | NUCLEIC ACID ENCODING N-METHYLPUTRESCINE OXIDASE AND USES THEREOF | National Research Council of Canada (CA) | 2009-03-25 | — | — | EP | disclosed |
| WO-2008020333-A2 | NUCLEIC ACID ENCODING N-METHYLPUTRESCINE OXIDASE AND USES THEREOF | NATIONAL RESEARCH COUNCIL OF CANADA (US) | 2008-02-21 | — | — | WO | disclosed |
| EP-0656791-B1 | THERAPEUTIC COMPOSITIONS COMPRISING PQQ AND A REDUCING AGENT | CHILDRENS MEDICAL CENTER (US) | 2002-06-05 | — | — | EP | disclosed |
| EP-0656791-A4 | THERAPEUTIC COMPOSITIONS AND METHODS USING PQQ. | CHILDRENS MEDICAL CENTER (US) | 1997-08-20 | — | — | EP | disclosed |
| US-5460819-A | Method for treating PQQ-responsive heavy metal toxicity | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1995-10-24 | — | — | US | disclosed |
| EP-0656791-A1 | THERAPEUTIC COMPOSITIONS AND METHODS USING PQQ | The Children's Medical Center Corporation (US) | 1995-06-14 | — | — | EP | disclosed |
| WO-1994001142-A1 | THERAPEUTIC COMPOSITIONS AND METHODS USING PQQ | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1994-01-20 | — | — | WO | disclosed |